QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 cantor-fitzgerald-maintains-overweight-on-mimedx-group-raises-price-target-to-12

Cantor Fitzgerald analyst Ross Osborn maintains MiMedx Group (NASDAQ:MDXG) with a Overweight and raises the price target fro...

 mimedx-group-and-vaporox-collaborate-to-co-promote-and-co-market-their-wound-care-offerings

MiMedx Group, Inc. (NASDAQ:MDXG) ("MIMEDX" or the "Company") and Vaporox, Inc. ("Vaporox") today jointl...

 cantor-fitzgerald-reiterates-overweight-on-mimedx-group-maintains-11-price-target

Cantor Fitzgerald analyst Ross Osborn reiterates MiMedx Group (NASDAQ:MDXG) with a Overweight and maintains $11 price target.

 mimedx-group-form4-filing-shows-ceo-joseph-capper-bought-200000-shares-of-stock-at-an-average-price-of-634share

- SEC Filing

 mimedx-group-q1-adj-eps-006-inline-sales-8820m-beat-8620m-estimate

MiMedx Group (NASDAQ:MDXG) reported quarterly earnings of $0.06 per share which met the analyst consensus estimate. This is a 1...

 cantor-fitzgerald-reiterates-overweight-on-mimedx-group-maintains-13-price-target

Cantor Fitzgerald analyst Ross Osborn reiterates MiMedx Group (NASDAQ:MDXG) with a Overweight and maintains $13 price target.

 mimedx-group-q4-adj-007-inline-sales-9291m-beat-8942m-estimate

MiMedx Group (NASDAQ:MDXG) reported quarterly earnings of $0.07 per share which met the analyst consensus estimate. This is a 7...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION